Co-founder & CEO of Rebis (acquired $60M); later led commercialisation at Cyra Technologies.
30+ years commercialising high-technology innovation, including 20+ years in Medtech CEO roles.
Professor of Colorectal Surgery and adult lead of the NZ National Intestinal Failure Service.
Former Managing Director of Brandwood Biomedical NZ; early investor and development team member at Aroa Biosurgery.
20+ years in MedTech and Life Sciences; led ConvaTec's US$1.8B IPO on the London Stock Exchange.
Biomedical engineer specialising in clinical collaboration, medical-technology development and the improvement of company operations.
Mechanical engineer and entrepreneur experienced in developing disruptive, patented and award-winning medical technologies.
International clinical nutrition specialist with senior roles across leading professional societies, including the British Pharmaceutical Nutrition Group and ASPEN.
Colorectal surgeon and nutritionist specialising in parenteral nutrition, temporary double enterostomies and chyme reinfusion therapy.
Experienced stomal therapist providing clinical education and hands-on support for patients using chyme reinfusion therapy across Europe.
Stomal therapy specialist with extensive experience supporting patients with enterostomies, intestinal fistulas and chyme reinfusion therapy.
Clinician-researcher specialising in postoperative gut function, gastrointestinal recovery, patient outcomes and collaborative clinical research.
Medical-device commercial leader with more than 30 years of experience in international sales, marketing and senior management.
Healthcare executive with extensive experience developing commercial strategies and launching medical and nutritional products across Europe.
International business-development specialist with 20 years of experience managing global distributor networks across multiple medical-device specialties.
MedTech commercialisation specialist with experience in human physiology, technology transfer, international sales and strategic partnerships.
Quality and regulatory specialist with more than 25 years of healthcare experience across medical-device and digital-health companies.
Commercialising decades of clinical experience in intestinal surgery into breakthrough medical devices
The Insides Company brings together clinical expertise, medical technology, education and international partnerships to help people recovering from severe intestinal conditions.
Our work is focused on making chyme reinfusion therapy more accessible and establishing a new standard of care.
We listen to patients, clinicians and one another so we understand the real need and act with purpose.
© 2026 The Insides Company. All copyright, design, patent and intellectual property rights existing in our designs and products and in the images, text and design of our website / marketing material are the property of The Insides Company.
.png){kind=small}
.png){kind=small}
